English
Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Solara Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Solara Active Pharma Sciences

    Small Cap
    ₹749.5
    +13.15 (1.79%)
    21 September, 2024 04:30 BSE: 541540 NSE: SOLARAISIN: INE624Z01016

    Start SIP in Solara Active Pharma Sciences

    Start SIP

    Solara Active Pharma Sciences Performance

    Day Range

    • Low 731
    • High 750
    ₹ 749

    52 Week Range

    • Low 264
    • High 814
    ₹ 749
    • Open Price738
    • Previous Close736
    • Volume53616

    Solara Active Pharma Sciences Share Price

    • Over 1 Month +18.59%
    • Over 3 Month +78.33%
    • Over 6 Month +120.27%
    • Over 1 Year +125.52%

    Solara Active Pharma Sciences Key Statistics

    P/E Ratio -5.4
    PEG Ratio 0
    Market Cap Cr
    Price to Book Ratio 3.2
    EPS -113.3
    Dividend 0
    Relative Strength Index 58.14
    Money Flow Index 79.11
    MACD Signal 30.59
    Average True Range 36
    Solara Active Pharma Sciences Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 363299249425352381
    Operating Expenses Qtr Cr 321290410388333329
    Operating Profit Qtr Cr 4210-162381952
    Depreciation Qtr Cr 252526262626
    Interest Qtr Cr 313125242622
    Tax Qtr Cr 08900-102
    Net Profit Qtr Cr -12-256-275-15-206
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,2941,466
    Operating Expenses Annual Cr 1,3841,310
    Operating Profit Annual in Cr -95134
    Depreciation Cr 103111
    Interest Annual Cr 10690
    Tax Annual Cr 79-23
    Net Profit Annual Cr -567-22
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 111156
    Cash from Investing Activity Annual Cr -5-81
    Cash from Financing Annual Activity Cr -107-113
    Net Cash Flow Annual Cr 0-38
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 9371,503
    Fixed Assets Annual Cr 1,5171,580
    Total Non Current Assets Annual Cr 1,5561,704
    Total Current Assets Annual Cr 7911,191
    Total Assets Annual Cr 2,3472,895
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 260418
    ROE Annual % -60-1
    ROCE Annual % -173
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -711
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 363299249425352381
    Operating Expenses Qtr Cr 322290410388333332
    Operating Profit Qtr Cr 4210-162381949
    Depreciation Qtr Cr 252526262626
    Interest Qtr Cr 313125242522
    Tax Qtr Cr 08900-101
    Net Profit Qtr Cr -13-255-275-17-204
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,2941,466
    Operating Expenses Annual Cr 1,3841,310
    Operating Profit Annual in Cr -95134
    Depreciation Cr 103111
    Interest Annual Cr 10590
    Tax Annual Cr 79-23
    Net Profit Annual Cr -567-22
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 109156
    Cash from Investing Activity Annual Cr -4-81
    Cash from Financing Annual Activity Cr -106-113
    Net Cash Flow Annual Cr 0-38
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 9341,500
    Fixed Assets Annual Cr 1,1591,237
    Total Non Current Assets Annual Cr 1,5501,712
    Total Current Assets Annual Cr 8011,188
    Total Assets Annual Cr 2,3512,899
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 260417
    ROE Annual % -61-1
    ROCE Annual % -173
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -711
    Invest in Solara Active Pharma Sciences

    Solara Active Pharma Sciences Technicals

    EMA & SMA

    Current Price
    ₹749.5
    +13.15 (1.79%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹733.44
    • 50 Day
    • ₹674.75
    • 100 Day
    • ₹600.47
    • 200 Day
    • ₹519.15
    • 20 Day
    • ₹739.39
    • 50 Day
    • ₹670.86
    • 100 Day
    • ₹574.80
    • 200 Day
    • ₹475.19

    Solara Active Pharma Sciences Resistance and Support

    PIVOT
    ₹743.5
    Resistance
    First Resistance 756.00
    Second Resistance 762.50
    Third Resistance 775.00
    RSI 58.14
    MFI 79.11
    MACD Single Line 30.59
    MACD 24.58
    Support
    First Support 737.00
    Second Support 724.50
    Third Supoort 718.00

    Solara Active Pharma Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 55,462 5,546,200 100
    Week 42,579 4,257,880 100
    1 Month 86,290 8,629,032 100
    6 Month 343,848 12,956,187 37.68

    Solara Active Pharma Sciences Result Highlights

    Solara Active Pharma Sciences Synopsis

    NSE-Medical-Diversified

    Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1288.92 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2024. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.
    Market Cap 2,960
    Sales 1,337
    Shares in Float 2.53
    No of funds 50
    Yield
    Book Value 3.07
    U/D Vol ratio 1.5
    LTDebt / Equity 11
    Alpha 0.22
    Beta 1.29

    Solara Active Pharma Sciences Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 37.27%30.49%30.49%37.19%
    Mutual Funds 1.28%1.71%1.71%1.75%
    Foreign Portfolio Investors 14%15.8%16.62%17.86%
    Financial Institutions/ Banks 0.04%0.04%
    Individual Investors 19.61%20.15%20.96%19.84%
    Others 27.84%31.81%30.22%23.32%

    Solara Active Pharma Sciences Management

    Name Designation
    Mr. R Ramakrishnan Chairman & Ind.Director
    Mr. Poorvank Purohit Managing Director & CEO
    Mr. Mohan Muthunarayanan COO & Executive Director
    Mr. Manish Gupta Non Executive Director
    Mr. Kartheek Chintalapati Raju Non Executive Director
    Mr. Arun Kumar Non Executive Director
    Dr. Kausalya Santhanam Independent Director
    Mr. Rajiv Vijay Nabar Independent Director
    Mr. Rajendra Kumar Srivastava Independent Director

    Solara Active Pharma Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Solara Active Pharma Sciences Corporate Action

    Date Purpose Remarks
    2024-07-22 Quarterly Results
    2024-05-29 Audited Results
    2024-05-09 To consider Fund Raising
    2024-02-14 Quarterly Results
    2023-11-14 Quarterly Results

    Solara Active Pharma Sciences MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Flexi Cap Fund Growth 23,228
    Aditya Birla Sun Life Mid Cap Fund Growth 6,149
    Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth 1,191

    Solara Active Pharma Sciences FAQs

    What is Share Price of Solara Active Pharma Sciences ?

    Solara Active Pharma Sciences share price is ₹749 As on 21 September, 2024 | 04:16

    What is the Market Cap of Solara Active Pharma Sciences ?

    The Market Cap of Solara Active Pharma Sciences is ₹3013.3 Cr As on 21 September, 2024 | 04:16

    What is the P/E ratio of Solara Active Pharma Sciences ?

    The P/E ratio of Solara Active Pharma Sciences is -5.4 As on 21 September, 2024 | 04:16

    What is the PB ratio of Solara Active Pharma Sciences ?

    The PB ratio of Solara Active Pharma Sciences is 3.2 As on 21 September, 2024 | 04:16

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.